| abstract |
Various aspects of the disclosure include compounds that activate Nrf2. Such compounds are useful in the treatment of autoimmune and inflammatory diseases and disorders, such as, for example, psoriasis and multiple sclerosis. Various embodiments of the present disclosure are also directed to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and conditions, processes for preparing these compounds and intermediates useful in these processes. |